The FDA’s Office of Prescription Drug Promotion says Pacira’s promotional materials for Exparel are “extremely concerning,” but the drugmaker tells investors the fuss is probably because opioids have been getting a lot of attention lately.
FYI: FDA habla español
August 6, 2014
4:08 pm
The FDA issued a Warning Letter over unapproved drug claims published in Spanish.
Vet drugmakers get Warning Letters too
July 16, 2014
5:47 pm
Regulatory Focus reports that the regulator has issued a Warning Letter to AB Science for marketing its canine tumor drug Kinavet for unapproved, off-label uses.